Article
The first generic version of Accutane (isotretinoin), approved Nov. 11 by the FDA, reached market in late November at a price approximately 5.5 percent lower than the brand name.
Reviewing Complex Cases: Psoriasis in Older Patients
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
James Del Rosso, DO, on What’s New in the Medicine Chest
First Patient Dosed in Phase 1 Study of Attovia's ATTO-1310 for Chronic Pruritus